EVOTEC SE (1EVT.MI) Fundamental Analysis & Valuation
BIT:1EVT • DE0005664809
Current stock price
4.226 EUR
-1.03 (-19.63%)
Last:
This 1EVT.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. 1EVT.MI Profitability Analysis
1.1 Basic Checks
- 1EVT had negative earnings in the past year.
- In the past year 1EVT had a positive cash flow from operations.
- In multiple years 1EVT reported negative net income over the last 5 years.
- Each year in the past 5 years 1EVT had a positive operating cash flow.
1.2 Ratios
- 1EVT's Return On Assets of -8.97% is on the low side compared to the rest of the industry. 1EVT is outperformed by 77.78% of its industry peers.
- 1EVT has a Return On Equity of -19.87%. This is in the lower half of the industry: 1EVT underperforms 72.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.97% | ||
| ROE | -19.87% | ||
| ROIC | N/A |
ROA(3y)-7.25%
ROA(5y)-2.34%
ROE(3y)-14.29%
ROE(5y)-5.27%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- 1EVT's Gross Margin of 10.82% is on the low side compared to the rest of the industry. 1EVT is outperformed by 83.33% of its industry peers.
- In the last couple of years the Gross Margin of 1EVT has declined.
- 1EVT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 10.82% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.23%
GM growth 5Y-13.5%
2. 1EVT.MI Health Analysis
2.1 Basic Checks
- 1EVT does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, 1EVT has more shares outstanding
- The number of shares outstanding for 1EVT has been increased compared to 5 years ago.
- Compared to 1 year ago, 1EVT has an improved debt to assets ratio.
2.2 Solvency
- 1EVT has an Altman-Z score of 0.83. This is a bad value and indicates that 1EVT is not financially healthy and even has some risk of bankruptcy.
- 1EVT's Altman-Z score of 0.83 is on the low side compared to the rest of the industry. 1EVT is outperformed by 83.33% of its industry peers.
- A Debt/Equity ratio of 0.48 indicates that 1EVT is not too dependend on debt financing.
- 1EVT has a better Debt to Equity ratio (0.48) than 77.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.83 |
ROIC/WACCN/A
WACC8.01%
2.3 Liquidity
- A Current Ratio of 2.12 indicates that 1EVT has no problem at all paying its short term obligations.
- Looking at the Current ratio, with a value of 2.12, 1EVT belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
- A Quick Ratio of 2.03 indicates that 1EVT has no problem at all paying its short term obligations.
- Looking at the Quick ratio, with a value of 2.03, 1EVT belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.12 | ||
| Quick Ratio | 2.03 |
3. 1EVT.MI Growth Analysis
3.1 Past
- The earnings per share for 1EVT have decreased strongly by -136.17% in the last year.
- 1EVT shows a decrease in Revenue. In the last year, the revenue decreased by -2.67%.
- Measured over the past years, 1EVT shows a quite strong growth in Revenue. The Revenue has been growing by 12.29% on average per year.
EPS 1Y (TTM)-136.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8.5%
Revenue 1Y (TTM)-2.67%
Revenue growth 3Y8.85%
Revenue growth 5Y12.29%
Sales Q2Q%-11.36%
3.2 Future
- The Earnings Per Share is expected to grow by 19.75% on average over the next years. This is quite good.
- Based on estimates for the next years, 1EVT will show a small growth in Revenue. The Revenue will grow by 6.85% on average per year.
EPS Next Y59.73%
EPS Next 2Y35.6%
EPS Next 3Y28%
EPS Next 5Y19.75%
Revenue Next Year-2.27%
Revenue Next 2Y4.05%
Revenue Next 3Y6.5%
Revenue Next 5Y6.85%
3.3 Evolution
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. 1EVT.MI Valuation Analysis
4.1 Price/Earnings Ratio
- 1EVT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year 1EVT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, 1EVT is valued a bit more expensive than the industry average as 77.78% of the companies are valued more cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 905.71 |
4.3 Compensation for Growth
- 1EVT's earnings are expected to grow with 28.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.6%
EPS Next 3Y28%
5. 1EVT.MI Dividend Analysis
5.1 Amount
- 1EVT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
1EVT.MI Fundamentals: All Metrics, Ratios and Statistics
BIT:1EVT (3/16/2026, 7:00:00 PM)
4.226
-1.03 (-19.63%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)N/A N/A
Inst Owners60.42%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.50B
Revenue(TTM)756.33M
Net Income(TTM)-158.98M
Analysts78.46
Price Target9.56 (126.22%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.97%
Min Revenue beat(2)-9.17%
Max Revenue beat(2)-4.77%
Revenue beat(4)0
Avg Revenue beat(4)-4.99%
Min Revenue beat(4)-9.17%
Max Revenue beat(4)-0.93%
Revenue beat(8)1
Avg Revenue beat(8)-3.74%
Revenue beat(12)4
Avg Revenue beat(12)1.1%
Revenue beat(16)7
Avg Revenue beat(16)2.93%
PT rev (1m)1.15%
PT rev (3m)-1.81%
EPS NQ rev (1m)366.67%
EPS NQ rev (3m)300%
EPS NY rev (1m)5.49%
EPS NY rev (3m)-54.9%
Revenue NQ rev (1m)7.16%
Revenue NQ rev (3m)-6.47%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.79%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.98 | ||
| P/FCF | N/A | ||
| P/OCF | 1064.31 | ||
| P/B | 1.88 | ||
| P/tB | 3 | ||
| EV/EBITDA | 905.71 |
EPS(TTM)-1.11
EYN/A
EPS(NY)-0.18
Fwd EYN/A
FCF(TTM)-0.26
FCFYN/A
OCF(TTM)0
OCFY0.09%
SpS2.13
BVpS2.25
TBVpS1.41
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.97% | ||
| ROE | -19.87% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 10.82% | ||
| FCFM | N/A |
ROA(3y)-7.25%
ROA(5y)-2.34%
ROE(3y)-14.29%
ROE(5y)-5.27%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.23%
GM growth 5Y-13.5%
F-Score4
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 209.82 | ||
| Cap/Depr | 90.72% | ||
| Cap/Sales | 12.19% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 76.3% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.12 | ||
| Quick Ratio | 2.03 | ||
| Altman-Z | 0.83 |
F-Score4
WACC8.01%
ROIC/WACCN/A
Cap/Depr(3y)186.39%
Cap/Depr(5y)182.37%
Cap/Sales(3y)22.79%
Cap/Sales(5y)21.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-136.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8.5%
EPS Next Y59.73%
EPS Next 2Y35.6%
EPS Next 3Y28%
EPS Next 5Y19.75%
Revenue 1Y (TTM)-2.67%
Revenue growth 3Y8.85%
Revenue growth 5Y12.29%
Sales Q2Q%-11.36%
Revenue Next Year-2.27%
Revenue Next 2Y4.05%
Revenue Next 3Y6.5%
Revenue Next 5Y6.85%
EBIT growth 1Y-6.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year132.47%
EBIT Next 3Y50.57%
EBIT Next 5Y33.86%
FCF growth 1Y52.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y107.69%
OCF growth 3Y-46.98%
OCF growth 5Y-15.47%
EVOTEC SE / 1EVT.MI Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for EVOTEC SE?
ChartMill assigns a fundamental rating of 3 / 10 to 1EVT.MI.
What is the valuation status for 1EVT stock?
ChartMill assigns a valuation rating of 1 / 10 to EVOTEC SE (1EVT.MI). This can be considered as Overvalued.
What is the profitability of 1EVT stock?
EVOTEC SE (1EVT.MI) has a profitability rating of 1 / 10.
Can you provide the financial health for 1EVT stock?
The financial health rating of EVOTEC SE (1EVT.MI) is 5 / 10.